Designing the Optimal Radiopharmaceutical: Matching Target, Ligand Design, Radionuclide and Disease Biology
Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 11:00
Designing the Optimal Radiopharmaceutical: Matching Target, Ligand Design, Radionuclide and Disease Biology was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.
Speakers
- Guangzhou Han — Speaker Chief Scientific Officer, RadAlliance Therapeutics Inc